Proteasome inhibitors
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference63 articles.
1. The ubiquitin–proteasome pathway is required for processing the NF-κB1 precursor protein and activation of NF-κB;Palombella;Cell,1994
2. The proteasome;Adams;Nat. Rev. Cancer,2004
3. Novel targeted agents in the treatment of multiple myeloma;Varga;Hematol. Oncol. Clin. North Am.,2014
4. Current treatment landscape for relapsed and/or refractory multiple myeloma;Dimopoulos;Nat. Clin. Oncol.,2015
5. The proteasome inhibitor PS-341 in cancer therapy;Teicher;Clin. Cancer Res.,1999
Cited by 148 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction;International Journal of Molecular Sciences;2024-08-16
2. TurboID‐based proteomic profiling reveals proxitome of ASK1 and CUL1 of the SCF ubiquitin ligase in plants;New Phytologist;2024-07-30
3. Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma;International Journal of Molecular Sciences;2024-07-16
4. Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases;Signal Transduction and Targeted Therapy;2024-07-12
5. Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma;Clinical and Translational Science;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3